—

Grifols S.A.(GRF.MC)— 同类公司组

数据截至2026-10-08 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Grifols S.A.的Closelook综合评分为49/100,在同类公司组内排名第13位(共13家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
GRF.MC Grifols S.A.49544579info20.1%
LLY Eli Lilly and Company64699229bull8%
ORNAV.HE Orion Oyj A62798434ok4.6%
ORNBV.HE Orion Oyj B62808434ok4.4%
AMGN Amgen Inc55778542bull7.6%
NVO Novo Nordisk A/S55258775bear38.2%
GSK GlaxoSmithKline PLC ADR52268058info22.6%
ROVI.MC Laboratorios Farmaceuticos ROVI61277752warn31.8%
ALM.MC Almirall S.A.53224668warn27.1%
HALO Halozyme Therapeutics Inc74949451ok6%
BION.SW BB Biotech AG73579681info16.1%
DXCM DexCom Inc66838037watch9%
ANN.AU Ansell Ltd64944753ok1.7%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-08

Quick answers

Grifols S.A.在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Eli Lilly and Company (LLY)、Orion Oyj A (ORNAV.HE)、Orion Oyj B (ORNBV.HE)、Amgen Inc (AMGN)、Novo Nordisk A/S (NVO)、GlaxoSmithKline PLC ADR (GSK)、Laboratorios Farmaceuticos ROVI (ROVI.MC)、Almirall S.A. (ALM.MC)等。

GRF.MC相对同类公司的评分如何?

Grifols S.A.的综合评分为49/100,组内排名第13位(共13家),截至2026-10-08;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.